probiotic supplementation intervention: probiotic supplementation will be administered, while participants continue undergoing standard postoperative care
Placebo supplementation intervention: Undergo routine standard postoperative care with placebo intervention
Study summary
This study aims to investigate the distribution of gut microbiota-derived metabolites, and to evaluate whether postoperative nutritional intervention can modulate the gut-heart metabolic axis, thereby improving metabolic profiles and clinical outcomes.
Eligibility
Sex
ALL
Min age
50 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Scheduled to undergo cardiovascular surgery
* Completed preoperative clinical and imaging evaluations
* Willing to provide informed consent
* Willing to receive potential probiotic supplementation
Exclusion Criteria:
* Use of antibiotics, probiotics, or other treatments affecting gut microbiota within 4 weeks
* History of major gastrointestinal disease
Primary outcome measure(s)
Trimethylamine-N-oxide — From enrollment to the end of intervention at 3 weeks Gut microbiota-derived metabolites
Phenylacetylglutamine — From enrollment to the end of intervention at 3 weeks Gut microbiota-derived metabolites
P-cresyl sulfate — From enrollment to the end of intervention at 3 weeks Gut microbiota-derived metabolites
Indoxyl sulfate — From enrollment to the end of intervention at 3 weeks Gut microbiota-derived metabolites
Trial sites (1)
Facility
City
Region
Status
Fu Jen Catholic University Hospital, Fu Jen Catholic University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.